Literature DB >> 9460323

Recruitment of African Americans into prostate cancer screening.

S P Weinrich1, M D Boyd, D Bradford, M S Mossa, M Weinrich.   

Abstract

PURPOSE: Both incidence and mortality rates for prostate cancer are significantly higher in African American men than in white men. This report identifies community sites for the optimal recruitment of African American men into prostate cancer screening. DESCRIPTION OF STUDY: A descriptive study was conducted, providing an educational program to 1369 African American men, 1264 of whom completed a survey on demographic data, prostate cancer knowledge, and prostate cancer screening history. The programs were offered at six different types of community sites, including various work sites, churches, housing projects, National Association for Advancement of Colored Persons (NAACP) sites, barber shops, and a state fairground. Free prostate cancer screening was offered to all participants.
RESULTS: The advertised mass screening site (state fairground), the most common method used nationally to recruit African American men for cancer screening, was the least effective site, with only 16 men completing the survey. Of the 1264 men completing the survey at all community sites, 597 men (47%) did so at work sites and 438 (35%) did so at churches. Per site, the largest percentage of men who had never been screened was at work sites (n = 276, 46%) and NAACP sites (n = 22, 33.8%). The highest percentage of men who obtained free screening were at the state fairground (14 of 16), churches (256 of 438), and work sites (336 of 597). The most prostate cancers were detected at the housing projects, where 3 of 38 (7.9%) men who were screened received diagnoses of prostate cancer. CLINICAL IMPLICATIONS: To reduce prostate mortality rates in African American men, healthcare providers need to make a concerted effort to increase prostate cancer education and screening in this population. To be effective, recruitment of African American men must move from a provider/health site orientation to a consumer/community orientation. These findings indicate that recruitment strategies are more successful if efforts are based in the community or where a large number of African American men live and/or work. Because a history of screening has been shown to be a predictor for current participation, programs need to target men who have not had previous screening ever or within the last year. In addition, the large percentage of men recruited at work sites who had not been screened previously indicates an opportunity for collaboration with healthcare professionals in employee health programs. Efforts to increase participation in prostate cancer screening will be enhanced significantly by eliciting the active involvement of community leaders.

Entities:  

Mesh:

Year:  1998        PMID: 9460323     DOI: 10.1046/j.1523-5394.1998.1998006023.x

Source DB:  PubMed          Journal:  Cancer Pract        ISSN: 1065-4704


  14 in total

1.  Life cycle of the African-American male: improving survival outcomes.

Authors:  G C Dennis
Journal:  J Natl Med Assoc       Date:  1999-01       Impact factor: 1.798

2.  Beauty and the beast: results of the Rhode Island smokefree shop initiative.

Authors:  Laura A Linnan; Karen M Emmons; David B Abrams
Journal:  Am J Public Health       Date:  2002-01       Impact factor: 9.308

Review 3.  Health programs in faith-based organizations: are they effective?

Authors:  Mark J DeHaven; Irby B Hunter; Laura Wilder; James W Walton; Jarett Berry
Journal:  Am J Public Health       Date:  2004-06       Impact factor: 9.308

4.  Development of a spiritually based educational intervention to increase informed decision making for prostate cancer screening among church-attending African American men.

Authors:  Cheryl L Holt; Theresa A Wynn; Penny Southward; Mark S Litaker; Sanford Jeames; Emily Schulz
Journal:  J Health Commun       Date:  2009-09

5.  Prostate Cancer Education, Detection, and Follow-Up in a Community-Based Multiethnic Cohort of Medically Underserved Men.

Authors:  Omotola S Ashorobi; Jacqueline Frost; Xuemei Wang; Pamela Roberson; E Lin; Robert J Volk; David S Lopez; Lovell A Jones; Curtis A Pettaway
Journal:  Am J Mens Health       Date:  2016-07-08

6.  Lessons Learned from Implementing a Prostate Cancer Risk Assessment Program for Underserved High-Risk Men in the Community: the Prostate REACH Project.

Authors:  Linda Fleisher; Stacy N Davis; Laura Gross; Loretta Bagden; Debra Zakrzewski; Evelyn González; Venk Kandadai; Cheryl Rusten; Jerilyn Baskett; Elias Obeid; Veda N Giri
Journal:  J Cancer Educ       Date:  2016-03       Impact factor: 2.037

7.  Knowledge, beliefs and barriers associated with prostate cancer prevention and screening behaviors among African-American men.

Authors:  Deborah E Blocker; LaHoma Smith Romocki; Kamilah B Thomas; Belinda L Jones; Ethel Jean Jackson; LaVerne Reid; Marci K Campbell
Journal:  J Natl Med Assoc       Date:  2006-08       Impact factor: 1.798

8.  Substantial family history of prostate cancer in black men recruited for prostate cancer screening: results from the Prostate Cancer Risk Assessment Program.

Authors:  Kathleen Mastalski; Elliot J Coups; Karen Ruth; Susan Raysor; Veda N Giri
Journal:  Cancer       Date:  2008-11-01       Impact factor: 6.860

9.  A comparison of a spiritually based and non-spiritually based educational intervention for informed decision making for prostate cancer screening among church-attending African-American men.

Authors:  Cheryl L Holt; Theresa A Wynn; Mark S Litaker; Penny Southward; Sanford Jeames; Emily Schulz
Journal:  Urol Nurs       Date:  2009 Jul-Aug

10.  High prevalence of screen detected prostate cancer in West Africans: implications for racial disparity of prostate cancer.

Authors:  Ann W Hsing; Edward Yeboah; Richard Biritwum; Yao Tettey; Angelo M De Marzo; Andrew Adjei; George J Netto; Kai Yu; Yan Li; Anand P Chokkalingam; Lisa W Chu; David Chia; Alan Partin; Ian M Thompson; Sabah M Quraishi; Shelley Niwa; Robert Tarone; Robert N Hoover
Journal:  J Urol       Date:  2014-04-18       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.